Neuralstem ALS Stem Cell Trial Featured on Fox Atlanta
Neuralstem, Inc. (NYSE Amex: CUR) announced that the ongoing Phase I trial to test its spinal cord stem cells in amyotro…
Neuralstem, Inc. (NYSE Amex: CUR) announced that the ongoing Phase I trial to test its spinal cord stem cells in amyotro…
Die seit Dezember 2006 an der amerikanischen AMEX gelistete Neuralstem Inc. (WKN: A0MNDN, ISIN: US64127R302) gab im Juni…